Fluo Labs, Inc. is a premarket clinical stage medical device company pursuing innovative technology to provide drug-free relief of nasal allergy (i.e. hay fever) symptoms. They are inventing a whole new way for sufferers of seasonal allergies to get symptom relief, and ultimately improve their quality of life. The Fluo device is designed to use light therapy to reduce inflammation and temporarily alleviate allergy symptoms as a completely drug-free alternative to common allergy medications.
TearSolutions' lead product, called Lacripep, delivers what no other approved or pipeline drug has been able to: rapid healing of the ocular surface and...
Matt Patsky is CEO and Lead Portfolio Manager of the Trillium ESG Global Equity strategy and Portfolio Manager of the Trillium Sustainable Opportunities strategy....
NXgenPort (NGP), has designed an innovative and transformative technology to maximize remote care in cancer patients requiring an implantable chemo-port catheter. Combining proven chemo-port...
